Jim Simons's position in Pfizer is currently worth $273 Million. That's 0.42% of their equity portfolio (35th largest holding). The first Pfizer trade was made in Q4 2013. Since then Jim Simons bought shares fourteen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $370 Million, resulting in a loss of 26%.